Production is based on 200.000 recombinant silkworms which have been transformed with the GFP gene. Manufacturing proceeds according to the Carthagena protocol and is supported by the MAFF’s National Institute of Agrobiological Sciences.

Nikkei Biotech news release, June 9, 2015